Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Sona Nanotech Inc C.SONA

Alternate Symbol(s):  SNANF

Sona Nanotech Inc. is a nanotechnology life sciences company, which is engaged in developing targeted hyperthermia therapy. The Company has developed multiple methods for the manufacturing of various types of gold nanoparticles (GNR). It is engaged in research and development of its technology for use in multiplex diagnostic testing platforms and advanced biomedical applications. Its gold... see more

CSE:SONA - Post Discussion

Sona Nanotech Inc > It is over for a while
View:
Post by chris579457 on Nov 25, 2020 6:08pm

It is over for a while

It is over , no more 16$
 
I guess I could repeat myself here : 
 
1/ they will have to resubmit that application with changes 
2/ it will take some time again to do that 
3/ it costs money to do that, it is not free and every one there will need to be paid too for whatever work they do 
4/ time is running away from some companies in this Covid story because others do have already Rapid Testing product that is authorized and/or approved for sales and distribution like FDA and EUA including contract and sales that has started already 
Comment by FSDLONG on Nov 25, 2020 6:23pm
LAST TIME. Health Canada wants a cheap, saliva based rapid test. LOOK AT THERMA BRIGHT TODAY! You will surely miss out sooner than later.
Comment by Moemoney42 on Nov 25, 2020 7:06pm
I'd like to add  #5/ the company is virtually broke... who's gonna pony up a financing to pursue this further.... and at what price...? Not looking good..!
Comment by erfre16 on Nov 25, 2020 7:39pm
Don't forget, SONA is in a "junior" market (CSE) It's imply junior stratgies junior products junior decision junior success :) major risks :) Go nasdaq if you want to do more money and reduce risks... GLTA  
Comment by Trannychick on Nov 25, 2020 7:42pm
Canada will need a domestic supply of rapid testing. Just like what we are being told regarding vaccine, Canada will not be first in line. The pandemic is not going to be over for quite some time especially in Canada as we may be 4 months behind the US and UK with regard to the vaccine and the poop is really only now starting to hit the fan now. Perhaps this gives some time to buy at a really ...more  
Comment by erfre16 on Nov 25, 2020 7:51pm
It's like the fable (but not quite) : The Tortoise and the Hare The tortoise (sona) try to win the race, but the hare(Abbott) already win!!! ...and sona continue to run...but why?! LOOOL  
Comment by charlottesweb on Nov 25, 2020 8:37pm
A they stated they plan on buying 20m tests  already got 4m from abbot so 80 percent to go or 16m why do you think they give a shyte about wasting time for sona to go through all the hoops ( months of clinical trials) only to re submit it and go through ( months of Hc tests )  they em will have mopped up them from big players going woth the flow of over big nations and huge companies ...more  
Comment by Trannychick on Nov 25, 2020 9:02pm
A few questions:  Will we get the 16 million? If so, when? Is 16 million that large a number? Answers:  maybe, hard to say. Definitely not.
Comment by Pandora on Nov 26, 2020 12:37am
"On 28 October 2020, a European Commission Recommendation on COVID-19 testing strategies, including the use of rapid antigen tests was published. That recommendation calls for European Union/European Economic Area (EU/EEA) Member States and the United Kingdom (UK) to agree on criteria to be used for the selection of rapid antigen tests, and to share and discuss information regarding the ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities